This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Eri Inoue: Innovator in Peptide Research
Introduction
Eri Inoue is a prominent inventor based in Zama, Japan. She has made significant contributions to the field of peptide research, particularly in the development of angiotensin-converting enzyme inhibitors. Her work has implications for the treatment of hypertension and related health issues.
Latest Patents
Eri Inoue holds a patent for a peptide with an angiotensin-converting enzyme inhibitory effect. The peptide, Met-Lys-Pro, is obtained through chemical synthesis or hydrolysis of casein. This peptide serves as the active ingredient in angiotensin-converting enzyme inhibitors or hypotensive drugs, showcasing her innovative approach to medical science.
Career Highlights
Inoue is associated with Morinaga Milk Industry Co., Ltd., where she applies her expertise in peptide synthesis and research. Her work at this company has allowed her to explore the potential of peptides in various therapeutic applications.
Collaborations
Eri Inoue has collaborated with notable colleagues, including Hiroshi Miyakawa and Hitoshi Saito. These partnerships have enhanced her research and contributed to the advancement of peptide technology.
Conclusion
Eri Inoue's contributions to peptide research and her innovative patent highlight her role as a leading inventor in the field. Her work continues to influence the development of effective treatments for hypertension and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile